Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Timing of Pulmozyme relative to chest physiotherapy in cystic fibrosis
ACTRN12607000155493Phase 4Completed
- Sponsor
- The Royal Children's Hospital
- Start
- May 2003
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of dornase alfa in cystic fibrosis (CF) (2 arms), sponsored by The Royal Children's Hospital. Primary endpoints: Forced expiratory volume in 1 second, Forced vital capacity and 3 more. Started May 2003; status: completed.
02
Drugs
dornase alfa
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on ACTRN12607000155493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12607000155493.